A Prospective, Randomized, Double-Blind, Crossover Comparison Evaluating Compatibility and Safety of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Patients With Type 1 Diabetes (PRONTO-Pump)
Phase of Trial: Phase III
Latest Information Update: 21 Sep 2018
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms PRONTO-Pump
- Sponsors Eli Lilly
- 13 Sep 2018 Status changed from active, no longer recruiting to completed.
- 26 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 01 Mar 2018 Status changed from not yet recruiting to recruiting.